Endothelial cell-specific overexpression of developmental endothelial locus-1 does not influence atherosclerosis development in ApoE-/- mice

Pallavi Subramanian; Marta Prucnal; Bettina Gercken; Matina Economopoulou; George Hajishengallis; Triantafyllos Chavakis

doi:10.1160/TH17-03-0160

Thrombosis and Haemostasis, Table of Contents

Thromb Haemost 2017; 117(10): 2003-2005
DOI: 10.1160/TH17-03-0160

Letter to the Editor

Schattauer GmbH

Endothelial cell-specific overexpression of developmental endothelial locus-1 does not influence atherosclerosis development in ApoE^-/- mice

Pallavi Subramanian

¹Institute for Clinical Chemistry and Laboratory Medicine, Medical Faculty, Technische Universität Dresden, Dresden, Germany

,

Marta Prucnal

¹Institute for Clinical Chemistry and Laboratory Medicine, Medical Faculty, Technische Universität Dresden, Dresden, Germany

,

Bettina Gercken

¹Institute for Clinical Chemistry and Laboratory Medicine, Medical Faculty, Technische Universität Dresden, Dresden, Germany

,

Matina Economopoulou

²Department of Ophthalmology, Faculty of Medicine, Technische Universität Dresden, Dresden, Germany

,

George Hajishengallis

³Department of Microbiology, University of Pennsylvania, Penn Dental Medicine, Philadelphia, Pennsylvania, USA

,

Triantafyllos Chavakis

¹Institute for Clinical Chemistry and Laboratory Medicine, Medical Faculty, Technische Universität Dresden, Dresden, Germany

› Author Affiliations

Abstract

Supplementary Material to this article is available online at www.thrombosis-online.com.

Full Text

References

References
1 Weber C, Noels H. Atherosclerosis: current pathogenesis and therapeutic options. Nature Med 2011; 17: 1410-1422.
2 Hansson GK, Hermansson A. The immune system in atherosclerosis. Nat Immunol 2011; 12: 204-212.
3 Tabas I, Garcia-Cardena G, Owens GK. Recent insights into the cellular biology of atherosclerosi. J Cell Biol 2015; 209: 13-22.
4 Weber C, Zernecke A, Libby P. The multifaceted contributions of leukocyte subsets to atherosclerosis: lessons from mouse models. Nature Rev Immunol 2008; 08: 802-815.
5 Viola J, Soehnlein O. Atherosclerosis – A matter of unresolved inflammation. Semin Immunol 2015; 27: 184-193.
6 Hansson GK, Libby P. The immune response in atherosclerosis: a double-edged sword. Nature Rev Immunol 2006; 06: 508-519.
7 Hidai C, Zupancic T, Penta K. et al. Cloning and characterization of developmental endothelial locus-1: an embryonic endothelial cell protein that binds the alphavbeta3 integrin receptor. Genes Dev 1998; 12: 21-33.
8 Chavakis T. Leucocyte recruitment in inflammation and novel endogenous negative regulators thereof. Eur J Clin Invest 2012; 42: 686-691.
9 Hajishengallis G, Chavakis T. Endogenous modulators of inflammatory cell recruitment. Trends Immunol 2013; 34: 1-6.
10 Hidai C, Kawana M, Kitano H. et al. Discoidin domain of Del1 protein contributes to its deposition in the extracellular matrix. Cell Tissue Res 2007; 330: 83-95.
11 Choi EY, Chavakis E, Czabanka MA. et al. Del-1, an endogenous leukocyte-endothelial adhesion inhibitor, limits inflammatory cell recruitment. Science 2008; 322: 1101-1104.
12 Mitroulis I, Kang YY, Gahmberg CG. et al. Developmental endothelial locus-1 attenuates complement-dependent phagocytosis through inhibition of Mac-1-integrin. Thromb Haemost 2014; 111: 1004-1006.
13 Hajishengallis G. Periodontitis: from microbial immune subversion to systemic inflammation. Nature Rev Immunol 2015; 15: 30-44.
14 Eskan MA, Jotwani R, Abe T. et al. The leukocyte integrin antagonist Del-1 inhibits IL-17-mediated inflammatory bone loss. Nat Immunol 2012; 13: 465-473.
15 Shin J, Maekawa T, Abe T. et al. DEL-1 restrains osteoclastogenesis and inhibits inflammatory bone loss in nonhuman primates. Sci Transl Med 2015; 07: 307ra155.
16 Maekawa T, Hosur K, Abe T. et al. Antagonistic effects of IL-17 and D-resolvins on endothelial Del-1 expression through a GSK-3beta-C/EBPbeta pathway. Nature communications 2015; 06: 8272.
17 Tabas I. Consequences and therapeutic implications of macrophage apoptosis in atherosclerosis: the importance of lesion stage and phagocytic efficiency. Arteri Thromb Vasc Biol 2005; 25: 2255-2264.
18 Littlewood TD, Bennett MR. Apoptotic cell death in atherosclerosis. Curr Opin Lipidol 2003; 14: 469-475.
19 Kakino A, Fujita Y, Nakano A. et al. Developmental Endothelial Locus-1 (Del-1) Inhibits Oxidized Low-Density Lipoprotein Activity by Direct Binding, and Its Overexpression Attenuates Atherogenesis in Mice. Circ J. 2016 Epub ahead of print.
20 Kourtzelis I, Kotlabova K, Lim JH. et al. Developmental endothelial locus-1 modulates platelet-monocyte interactions and instant blood-mediated inflammatory reaction in islet transplantation. Thromb Haemost 2016; 115: 781-788.
21 Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 2001; 25: 402-408.
22 Nam D, Ni CW, Rezvan A. et al. Partial carotid ligation is a model of acutely induced disturbed flow, leading to rapid endothelial dysfunction and atherosclerosis. Am J Physiol Heart Circ Physiol 2009; 297: H1535-H1543.
23 Freeley S, Kemper C, Le Friec G. The „ins and outs“ of complement-driven immune responses. Immunol Rev 2016; 274: 16-32.

Supplementary Material

Online Supplementary Material (PDF)